Ads

 

Ads

 

Ads

 

Maryland Top Companies List by Market Cap as of January 2024

Maryland Top Companies List by Market Cap as on Jan-05-2024. Biggest Maryland Companies List by Market Cap in January 2024. Maryland Largest Companies in January 2024.

Maryland Top Companies by Market Cap in 2024
Maryland Top Companies by Market Cap in 2024, Maryland Largest Companies in 2024, Biggest Maryland Companies by Market Cap.
  1. Legg Mason

    World Rank (Jan-05-2024)
    9,599
    World Rank (Jul-30-2023)
    9,599
    World Rank (Dec-25-2022)
    9,599
    World Rank (Jan-07-2022)
    9,599
    Headquarters Country
    Company Profile
    Legg Mason is a Investment management company. The company is a independent, specialized global investment managers with a combined $1.4 trillion in assets under management across one of the broadest ranges of high quality investment teams in the industry. It brings extensive capabilities in equity, fixed income, alternatives and custom multi asset solutions and employees in over 30 countries including 1,300 investment professionals. The headquarters is in USA.
  2. Centrus Energy

    World Rank (Jan-05-2024)
    9,721
    Market Cap (Jan-05-2024)
    0.809 Billion USD
    World Rank (Jul-30-2023)
    12,167
    Market Cap (Jul-30-2023)
    0.548 Billion USD
    World Rank (Dec-25-2022)
    13,000
    Market Cap (Dec-25-2022)
    0.457 Billion USD
    World Rank (Jan-07-2022)
    11,251
    Market Cap (Jan-07-2022)
    0.73 Billion USD
    Annual Revenue in USD
    293 Million USD
    Annual Operating Income in USD
    60 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  3. REGENXBIO Inc.

    World Rank (Jan-05-2024)
    10,026
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,791
    Market Cap (Jul-30-2023)
    0.818 Billion USD
    World Rank (Dec-25-2022)
    8,565
    Market Cap (Dec-25-2022)
    0.963 Billion USD
    World Rank (Jan-07-2022)
    8,285
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -262 Million USD
    Annual Net Income in USD
    -280 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    REGENXBIO is a Clinical Stage Biotechnology company. The company currently developing gene therapy product candidates for the treatment of retinal, metabolic and neurodegenerative diseases and provide long lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes. The headquarters is in USA.
  4. Medifast

    World Rank (Jan-05-2024)
    10,161
    Market Cap (Jan-05-2024)
    0.749 Billion USD
    World Rank (Jul-30-2023)
    7,972
    Market Cap (Jul-30-2023)
    1.166 Billion USD
    World Rank (Dec-25-2022)
    7,247
    Market Cap (Dec-25-2022)
    1.280 Billion USD
    World Rank (Jan-07-2022)
    5,484
    Market Cap (Jan-07-2022)
    2.49 Billion USD
    Annual Revenue in USD
    1,598 Million USD
    Annual Operating Income in USD
    184 Million USD
    Annual Net Income in USD
    143 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Medifast is a Multi Level Marketing company. It develops and manufacture most of foods in wholly owned manufacturing facility just steps from corporate offices in Baltimore, Maryland and clinical team continually strives to evolve product lines, while maintaining the highest quality at the fairest price. The headquarters is in USA.
  5. Rand Worldwide

    World Rank (Jan-05-2024)
    10,182
    World Rank (Jul-30-2023)
    10,182
    Market Cap (Jul-30-2023)
    0.765 Billion USD
    World Rank (Dec-25-2022)
    10,899
    Market Cap (Dec-25-2022)
    0.638 Billion USD
    World Rank (Jan-07-2022)
    13,110
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    222 Million USD
    Annual Net Income in USD
    12 Million USD
    Annual Results for Period Ending
    Jun-2019 ending year
    Headquarters Country
    Company Profile
    Rand Worldwide is the providers of technology solutions and professional services company to organizations with engineering design and information technology needs. It employs over 400 people in almost 50 locations around across North America. The headquarters is in USA.
  6. Global Medical Reit

    World Rank (Jan-05-2024)
    10,525
    Market Cap (Jan-05-2024)
    0.704 Billion USD
    World Rank (Jul-30-2023)
    10,763
    Market Cap (Jul-30-2023)
    0.690 Billion USD
    World Rank (Dec-25-2022)
    11,139
    Market Cap (Dec-25-2022)
    0.614 Billion USD
    World Rank (Jan-07-2022)
    8,716
    Market Cap (Jan-07-2022)
    1.15 Billion USD
    Annual Revenue in USD
    137 Million USD
    Annual Operating Income in USD
    39 Million USD
    Annual Net Income in USD
    13 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Global Medical REIT Inc. (NYSE: GMRE) is a Net Lease Medical Office Real Estate Investment Trust (REIT) company that acquires purpose built healthcare facilities and leases those facilities to strong healthcare systems and physician groups with market share. The headquarters is in USA.
  7. Altimmune Inc.

    World Rank (Jan-05-2024)
    11,224
    Market Cap (Jan-05-2024)
    0.628 Billion USD
    World Rank (Jul-30-2023)
    19,229
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    9,786
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    15,840
    Market Cap (Jan-07-2022)
    0.34 Billion USD
    Headquarters Country
    Company Profile
    Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases and intranasal vaccines. The company annual revenue is 8.1 million USD and total assets are 245 million USD as on 2020. The headquarters is in USA.
  8. Altimmune

    World Rank (Jan-05-2024)
    11,225
    Market Cap (Jan-05-2024)
    0.628 Billion USD
    World Rank (Jul-30-2023)
    19,230
    Market Cap (Jul-30-2023)
    0.160 Billion USD
    World Rank (Dec-25-2022)
    9,933
    Market Cap (Dec-25-2022)
    0.754 Billion USD
    World Rank (Jan-07-2022)
    16,056
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Net Income in USD
    -49 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  9. Argan

    World Rank (Jan-05-2024)
    11,261
    Market Cap (Jan-05-2024)
    0.624 Billion USD
    World Rank (Jul-30-2023)
    12,698
    Market Cap (Jul-30-2023)
    0.504 Billion USD
    World Rank (Dec-25-2022)
    12,477
    Market Cap (Dec-25-2022)
    0.495 Billion USD
    World Rank (Jan-07-2022)
    12,110
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Annual Revenue in USD
    509 Million USD
    Annual Net Income in USD
    38 Million USD
    Annual Results for Period Ending
    Jan-2022 ending year
    Headquarters Country
    Company Profile
    Argan is a Holding company that acquired and operates four wholly owned subsidiaries: Gemma Power Systems, The Roberts Company, Atlantic Projects Company and SMC Infrastructure Solutions. It provides a full range of engineering, procurement, construction, commissioning, operations management, maintenance, development, technical and consulting services to the power generation and renewable energy markets for a wide range of customers including independent power project owners, public utilities, power plant equipment suppliers and global energy plant construction firms.
  10. MacroGenics Inc.

    World Rank (Jan-05-2024)
    11,264
    Market Cap (Jan-05-2024)
    0.623 Billion USD
    World Rank (Jul-30-2023)
    16,045
    Market Cap (Jul-30-2023)
    0.289 Billion USD
    World Rank (Dec-25-2022)
    14,480
    Market Cap (Dec-25-2022)
    0.365 Billion USD
    World Rank (Jan-07-2022)
    9,924
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -202 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    MacroGenics is a Clinical Stage Biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody based therapeutics for the treatment of cancer. The company annual revenue is 64 million USD and  307 employees as on 2019. The headquarters is in USA.

Share

Ads